Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medtronic Inc Reaffirms FY 2014 Guidance-Conference Call


Tuesday, 20 Aug 2013 07:00am EDT 

Medtronic Inc announced that for fiscal 2014, it continue to believe that constant currency revenue growth of 3% to 4% remains reasonable and continue to expect non-GAAP diluted earnings per share (EPS) in the range of $3.80 to $3.85. The Company reported revenue of $16.590 billion in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $16.949 billion and EPS of $3.83 for fiscal 2014. 

Company Quote

63.45
-0.07 -0.11%
12:47pm EDT